🚀 VC round data is live in beta, check it out!
- Public Comps
- Integragen
Integragen Valuation Multiples
Discover revenue and EBITDA valuation multiples for Integragen and similar public comparables like Epigenomics, Ludwig Enterprises, 2cureX, NRGene and more.
Integragen Overview
About Integragen
Integragen is engaged in the development of genetic biomarkers. It offers genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics news, as well as genomic research tools and solutions to microbiologic researchers.
Founded
2000
HQ

Employees
43
Website
Sectors
Financials (FY)
Market Cap
$1M
Integragen Financials
Integragen reported last fiscal year revenue of $15M and negative EBITDA of ($157K).
In the same fiscal year, Integragen generated $6M in gross profit, ($157K) in EBITDA losses, and had net loss of ($199K).
Integragen P&L
In the most recent fiscal year, Integragen reported revenue of $15M and EBITDA of ($157K).
Integragen expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $15M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $6M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 40% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($157K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (1%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (1%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($199K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (1%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Integragen Stock Performance
Integragen has current market cap of $1M.
Market Cap Evolution
Integragen's stock price is $0.21.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $1M | (0.2%) | XXX | XXX | XXX | $-0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIntegragen Valuation Multiples
Integragen trades at 0.0x EV/Revenue multiple, and 1.0x EV/EBITDA.
Integragen Financial Valuation Multiples
As of March 7, 2026, Integragen has market cap of $1M.
Equity research analysts estimate Integragen's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Integragen has a P/E ratio of (6.8x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1M | XXX | $1M | XXX | XXX | XXX |
| EV (current) | ($152K) | XXX | ($152K) | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 1.1x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 0.0x | XXX | XXX | XXX |
| P/E | — | XXX | (6.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Integragen Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Integragen Margins & Growth Rates
Integragen's revenue in the last fiscal year grew by —.
Integragen Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Margin | — | XXX | (1%) | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 41% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Integragen Public Comps
See public comps and valuation multiples for other Diagnostics & Genomics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Epigenomics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ludwig Enterprises | XXX | XXX | XXX | XXX | XXX | XXX |
| 2cureX | XXX | XXX | XXX | XXX | XXX | XXX |
| NRGene | XXX | XXX | XXX | XXX | XXX | XXX |
| Biovica International | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Integragen M&A Activity
Integragen acquired XXX companies to date.
Last acquisition by Integragen was on XXXXXXXX, XXXXX. Integragen acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Integragen
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialIntegragen Investment Activity
Integragen invested in XXX companies to date.
Integragen made its latest investment on XXXXXXXX, XXXXX. Integragen invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Integragen
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Integragen
| When was Integragen founded? | Integragen was founded in 2000. |
| Where is Integragen headquartered? | Integragen is headquartered in France. |
| How many employees does Integragen have? | As of today, Integragen has over 43 employees. |
| Is Integragen publicly listed? | Yes, Integragen is a public company listed on Euronext Paris. |
| What is the stock symbol of Integragen? | Integragen trades under ALINT ticker. |
| When did Integragen go public? | Integragen went public in 2010. |
| Who are competitors of Integragen? | Integragen main competitors are Epigenomics, Ludwig Enterprises, 2cureX, NRGene. |
| What is the current market cap of Integragen? | Integragen's current market cap is $1M. |
| What is the current revenue of Integragen? | Integragen's last fiscal year revenue is $15M. |
| What is the current EV/Revenue multiple of Integragen? | Current revenue multiple of Integragen is 0.0x. |
| Is Integragen profitable? | No, Integragen is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.